Jury sides with Allergan in $56M Botox technology feud

$56M awarded to AbbVie unit in Delaware patent fight over Botox treatment | US Botox sales reportedly grew to over $4.4 billion last year, while trade secrets lawsuit against rival continues.

Already registered?

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More on this story

Big Pharma

AbbVie settles longstanding trade secret dispute with Evolus

23 February 2021 AbbVie and its Korean partner Medytox have settled a trade secret dispute with competitor Evolus over the sale of a rival botox competitor drug Jeuveau.

Americas

Fake botox seized in Cincinnati

31 July 2020 US authorities have seized thousands of dollars worth of counterfeit Botox injections in shipments in a Cincinnati port, the US Customs and Border Protection (CBP) office announced yesterday, July 30.

Big Pharma

Allergan says rivals using trade secrets disclosed by USITC order

13 August 2019 Allergan has filed a motion asking for its “trade secrets” to be removed from evidence in a dispute over its wrinkle treatment, Botox.

More on this story

Big Pharma

AbbVie settles longstanding trade secret dispute with Evolus

23 February 2021 AbbVie and its Korean partner Medytox have settled a trade secret dispute with competitor Evolus over the sale of a rival botox competitor drug Jeuveau.

Americas

Fake botox seized in Cincinnati

Big Pharma

Allergan says rivals using trade secrets disclosed by USITC order

13 August 2019 Allergan has filed a motion asking for its “trade secrets” to be removed from evidence in a dispute over its wrinkle treatment, Botox.

More on this story

Big Pharma

AbbVie settles longstanding trade secret dispute with Evolus

23 February 2021 AbbVie and its Korean partner Medytox have settled a trade secret dispute with competitor Evolus over the sale of a rival botox competitor drug Jeuveau.

Americas

Fake botox seized in Cincinnati

Big Pharma

Allergan says rivals using trade secrets disclosed by USITC order

13 August 2019 Allergan has filed a motion asking for its “trade secrets” to be removed from evidence in a dispute over its wrinkle treatment, Botox.